An overview of chronic kidney disease management and CAPD in the home. (cover story)An overview of chronic kidney disease management and CAPD in the home. (cover story)ChronickidneydiseaseContinuousambulatoryperitonealdialysisChronic kidney disease (CKD) is a common, harmful, but treatable long term...
An overview of chronic kidney disease management and CAPD in the home Jain,Neerja,Simoyi,... - 《Br J Community Nursing》 被引量: 5发表: 2008年 An overview of chronic kidney disease management and CAPD in the home. (cover story) An overview of chronic kidney disease management and CAPD ...
KIDNEY diseasesChronic kidney disease (CKD) is a severe condition and a significant public health issue worldwide, carrying the burden of an increased risk of cardiovascular events and mortality. The traditional factors that promote the onset and progression of CKD are cardiometabolic risk factors ...
Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences. Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable ...
AimThe burden of chronic kidney disease (CKD) is growing rapidly around the world. However, there is limited information on the overall regional prevalence of CKD, as well as the prognostic implications and treatment patterns in Asian region. We have established the Asian Renal Collaboration (ARC...
Approved by the FDA in 2021, finerenone is the only non-steroidal mineralocorticoid receptor antagonist that reduces the risk of renal disease progression and cardiovascular events in adults with type 2 diabetes mellitus-mediated chronic kidney disease.
• Chronic kidney disease. IgA nephropathy can cause your kidneys to gradually stop functioning. In such cases,permanent dialysis or a kidney transplant is needed to sustain life. • Nephroticsyndrome. This is a group of problems that can be caused by damage to the glomeruli, including high...
Overview of the cellular and molecular basis of kidney fibrosis - ScienceDirect The common pathogenetic pathway of progressive injury in patients with chronic kidney disease (CKD) is epitomized as normal kidney parenchymal destruction ... AA Eddy - 《Kidney International Supplements》 被引量: 151发表...
使用PPI还与新发慢性肾脏病(chronic kidney disease, CKD)、CKD进展以及终末期肾病风险增加相关。然而,目前尚不明确使用PPI与CKD风险相关的潜在机制,这些研究观察到的微弱关联可能由方法学局限性(残余混杂)引起。尚需开展进一步研究以帮助更好地阐明P...
Learn more about how to maintain your quality of life Learn more Life as a family memberAre you a family member or friend and facing the struggles of chronic kidney disease together with a loved one? Learn more I have kidney disease My therapy options My preparation for dialysis My life...